Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Gross Profit (2016 - 2025)

BioCorRx's Gross Profit history spans 15 years, with the latest figure at $134899.0 for Q1 2025.

  • For Q1 2025, Gross Profit rose 6807.27% year-over-year to $134899.0; the TTM value through Mar 2025 reached $138944.0, up 494.77%, while the annual FY2024 figure was $5998.0, 88.72% down from the prior year.
  • Gross Profit for Q1 2025 was $134899.0 at BioCorRx, up from $4045.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $134899.0 in Q1 2025 and bottomed at $1953.0 in Q1 2024.
  • The 5-year median for Gross Profit is $11182.0 (2021), against an average of $29001.6.
  • The largest annual shift saw Gross Profit tumbled 93.85% in 2024 before it soared 6807.27% in 2025.
  • A 5-year view of Gross Profit shows it stood at $11182.0 in 2021, then surged by 563.6% to $74204.0 in 2022, then tumbled by 92.07% to $5885.0 in 2023, then plummeted by 31.27% to $4045.0 in 2024, then soared by 3234.96% to $134899.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Gross Profit are $134899.0 (Q1 2025), $4045.0 (Q2 2024), and $1953.0 (Q1 2024).